Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of$ 0.90. This compares to loss of $1.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 32.22%. A quarter ago, it was expected that this company would post a loss of$ 0.98 per share when it actually produced a loss of $0.88, delivering a surprise of 10.20%.Over the last four quarters, the company ...